Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and urethral cancer ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Distal Urethral Cancer
• Proximal Urethral Cancer
• Transitional Cell Carcinoma of the Bladder
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Ixempra (ixabepilone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED